Department of Pathology, Kindai University Faculty of Medicine, 377-2 Ohno-higashi, Osaka-sayama, Osaka 589-8511, Japan.
Genome Medical Center, Kindai University Hospital, Osaka, Japan.
Life Sci. 2021 Oct 15;283:119854. doi: 10.1016/j.lfs.2021.119854. Epub 2021 Jul 29.
Cell adhesion molecule 1 (CADM1) mediates interepithelial adhesion and is upregulated in crowded epithelial monolayers. This study aimed to examine CADM1 expression in the human endometrium of proliferative and secretory phases, and its transcriptional regulation in terms of estrogen stimuli and higher cellularity.
CADM1 immunohistochemistry was conducted on endometrial tissues from women in their 40s and adult mice subcutaneously injected with estradiol following ovariectomy. Dual-luciferase reporter assays were conducted using human endometrial HEC-50B and HEC-1B cells and reporter plasmids harboring the human CADM1 3.4-kb promoter and its deleted and mutated forms. Cells were transfected with estrogen receptor α cDNA and reporter plasmids, and treated with estradiol before luciferase activity measurement.
Immunohistochemistry revealed that CADM1 was clearly expressed on the lateral membranes of the simple columnar glandular cells in the proliferative phase, but not in the secretory phase, from both women and the mouse model. The glandular cell density increased two-fold in the proliferative phase. Reporter assays identified three Sp1-binding sites as estradiol-responsive elements in the proximal region (from -223 to -84) of the transcription start site (+1) in HEC-50B cells. When the cell culture was started at eight-fold higher cell density, the CADM1 3.4-kb promoter was transactivated at a two-fold higher level in HEC-50B cells. This cell density effect was not detected for the CADM1 2.3-kb or 1.6-kb promoter.
Two (proximal and distal) promoter regions are suggested to function additively to transactivate CADM1 in endometrial glandular cells that crowd in the proliferative phase.
细胞黏附分子 1(CADM1)介导细胞间黏附,在细胞拥挤的上皮单层中上调。本研究旨在检测 CADM1 在人子宫内膜增生期和分泌期的表达及其在雌激素刺激和更高细胞密度下的转录调控。
对 40 多岁女性和接受卵巢切除术的成年小鼠皮下注射雌二醇后的子宫内膜组织进行 CADM1 免疫组织化学染色。使用人子宫内膜 HEC-50B 和 HEC-1B 细胞和携带人类 CADM1 3.4-kb 启动子及其缺失和突变形式的报告质粒进行双荧光素酶报告基因检测。细胞转染雌激素受体α cDNA 和报告质粒,并在测量荧光素酶活性前用雌二醇处理。
免疫组织化学显示,CADM1 在增生期的简单柱状腺细胞的侧膜上明显表达,但在分泌期不表达,无论是在女性还是在小鼠模型中都是如此。腺细胞密度在增生期增加了两倍。报告基因检测确定了三个 Sp1 结合位点,作为 HEC-50B 细胞转录起始位点(+1)近端(-223 至-84)的雌激素反应元件。当细胞培养密度增加到八倍时,HEC-50B 细胞中的 CADM1 3.4-kb 启动子的转录活性增加了两倍。在这种情况下,未检测到 CADM1 2.3-kb 或 1.6-kb 启动子的细胞密度效应。
两个(近端和远端)启动子区域被认为在增生期拥挤的子宫内膜腺细胞中协同激活 CADM1。